Results 261 to 270 of about 284,364 (303)

Postoperative Adjuvant Combined Modality Therapy

2001
Significant advances have been made in the adjuvant management of resectable rectal cancer during the 1990s. In patients with clinically resectable disease, pelvic radiation therapy decreases local recurrence. The addition of systemic chemotherapy further decreases local recurrence and improves survival.
B. D. Minsky, C. H. Kohne, C. Greco
openaire   +1 more source

Taxanes in Combined Modality Therapy

2003
The taxanes are a relatively new group of plant-derived chemotherapeutic agents that have been studied quite extensively in both preclinical studies and in clinical trials. This group of drugs, which includes paclitaxel (Taxol) and docetaxel (Taxotere), act as mitotic spindle inhibitors through their promotion of microtubule assembly and retardation of
Robert M. MacRae, Hak Choy
openaire   +1 more source

Adjuvant combined modality therapy for malignant meningiomas

Journal of Neurosurgery, 1996
✓ Malignant meningiomas constitute 10% to 15% of all meningiomas and limited information exists regarding adjuvant treatment of these aggressive primary brain tumors. Fourteen patients (eight men, six women), ranging in age from 28 to 61 years (median 51 years), were prospectively treated for primary malignant meningiomas according to an institutional ...
openaire   +2 more sources

Optimizing combined modality therapy for Hodgkin’s disease

International Journal of Radiation Oncology*Biology*Physics, 2003
cured of their Hodgkin’s disease. Of the 20%–25% who do relapse, the majority of these are cured with subsequent salvage programs employing either chemotherapy alone or combined modality therapy. The problem, of course, is what happens beyond 10 years. Patients treated with full-dose subtotal nodal radiotherapy, i.e., doses in the range of 40 Gy, will ...
openaire   +2 more sources

Combined modality therapy in NSCLC.

Annals of oncology : official journal of the European Society for Medical Oncology, 2001
Combined modality treatment has 'come out of age' and increasingly represents standard of care for a rapidly growing number of patients in locally advanced stages of NSCLC. Modern progress of treatment techniques as well as possibilities for supportive interventions will lead to lesser treatment toxicities, better patient's compliance to treatment ...
W, Eberhardt, S, Bildat, S, Korfee
openaire   +1 more source

Combining radiation therapy with other treatment modalities.

Seminars in veterinary medicine and surgery (small animal), 1995
Combining treatment modalities is indicated when single modality treatment does not result in adequate tumor control, or if the cosmetic or functional outcome of single modality treatment is less than desirable. The combination of surgery and radiation has proven useful in the treatment of both human and veterinary patients.
LARUE, SM, VUJASKOVIC, Z
openaire   +2 more sources

Taxanes in combined modality therapy for solid tumors

Critical Reviews in Oncology/Hematology, 2001
The taxanes, paclitaxel and docetaxel, are novel antimitotic agents that are under extensive investigation in clinical trials. Both taxanes have demonstrated significant activity against many solid tumors as single agents and in combination with other chemotherapeutic agents.
openaire   +3 more sources

Adjuvant combined modality therapy for rectal cancer

1998
Combined modality therapy is an integral component in the management of rectal cancer. There are two components of adjuvant therapy: pelvic radiation and 5-FU based chemotherapy. In patients with clinically resectable disease, the role of radiation therapy is to decrease local recurrence and increase the chance of sphincter preservation.
openaire   +2 more sources

Combined Modality Therapy

2013
Christin A. Knowlton, Michelle Kolton Mackay, Tod W. Speer, Robyn B. Vera, Douglas W. Arthur, David E. Wazer, Rachelle Lanciano, James H. Brashears, Christin A. Knowlton, Michelle Kolton Mackay, Filip T. Troicki, Jaganmohan Poli, Theodore E. Yaeger, Theodore E. Yaeger, Stephan Mose, Filip T. Troicki, Jaganmohan Poli, Anthony E. Dragun, Ramesh Rengan, Charles R. Thomas, Bernadine R. Donahue, Jay S. Cooper, Tod W. Speer, Filip T. Troicki, Jaganmohan Poli, Tod W. Speer, Patrizia Guerrieri, Paolo Montemaggi, Carsten Nieder, Tod W. Speer, John P. Christodouleas, Caspian Oliai, Theodore E. Yaeger, Curt Heese, Carlos A. Perez, Wade L. Thorstad, Darek Michalski, M. Saiful Huq, Christin A. Knowlton, Michelle Kolton Mackay, Brandon J. Fisher, Erik Limbergen, Bok Ai Choo, Jiade J. Lu, Luther W. Brady, Brandon J. Fisher, Larry C. Daugherty, Claudia Rübe, Daniel Yeung, Jatinder Palta, Bradley J. Huth, Anthony E. Dragun, Bradley J. Huth, Bradley J. Huth, Claudia E. Rübe, Jay E. Reiff, Theodore E. Yaeger, Theodore E. Yaeger, Tod W. Speer, Anthony E. Dragun, Carsten Nieder, Filip T. Troicki, Jaganmohan Poli, Volker Budach, Edward J. Gracely, Timothy Holmes, Daniel J. Scanderbeg, John P. Christodouleas, Timothy Holmes, Brandon J. Fisher, Larry C. Daugherty, Tod W. Speer, Johannes Classen, Stephan Mose, Curt Heese, George E. Laramore, Jay J. Liao, Jason K. Rockhill, Claudia Rübe   +78 more
openaire   +1 more source

[Combined-modality therapy for lung cancer].

Nihon rinsho. Japanese journal of clinical medicine, 2010
Lung cancer is treated with surgery, radiotherapy and chemotherapy according to histology and clinical stage. Advanced stage lung cancer patients cannot be cured, but early and locally-advanced stage patients can be cured by intensive combined-modality therapy. Combined-modality therapy with surgery plus adjuvant chemotherapy is standard for resectable
Satoru, Miura, Nobuyuki, Yamamoto
openaire   +1 more source